• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The global burden of psoriatic skin disease.

作者信息

Goff K L, Karimkhani C, Boyers L N, Weinstock M A, Lott J P, Hay R J, Coffeng L E, Norton S A, Naldi L, Dunnick C, Armstrong A W, Dellavalle R P

机构信息

University of South Carolina School of Medicine, Columbia, SC, U.S.A.

Columbia University College of Physicians and Surgeons, New York, NY, U.S.A.

出版信息

Br J Dermatol. 2015 Jun;172(6):1665-1668. doi: 10.1111/bjd.13715. Epub 2015 May 6.

DOI:10.1111/bjd.13715
PMID:25645671
Abstract
摘要

相似文献

1
The global burden of psoriatic skin disease.银屑病皮肤病的全球负担。
Br J Dermatol. 2015 Jun;172(6):1665-1668. doi: 10.1111/bjd.13715. Epub 2015 May 6.
2
Nail psoriasis in Germany: epidemiology and burden of disease.德国甲银屑病的流行病学和疾病负担。
Br J Dermatol. 2010 Sep;163(3):580-5. doi: 10.1111/j.1365-2133.2010.09831.x. Epub 2010 Apr 28.
3
1990-2010 global cardiovascular disease atlas.《1990 - 2010年全球心血管疾病图谱》
Glob Heart. 2014 Mar;9(1):3-16. doi: 10.1016/j.gheart.2014.03.1220.
4
Demographic and epidemiological drivers of global burden of psoriasis.银屑病全球负担的人口统计学和流行病学驱动因素。
Australas J Dermatol. 2021 Nov;62(4):e554-e558. doi: 10.1111/ajd.13710. Epub 2021 Sep 8.
5
Psoriasis epidemiology: the interplay of genes and the environment.银屑病的流行病学：基因与环境的相互作用。
J Invest Dermatol. 2013 Feb;133(2):287-9. doi: 10.1038/jid.2012.434.
6
[Disease burden of psoriasis associated with psoriatic arthritis in Hungary].[匈牙利银屑病关节炎相关银屑病的疾病负担]
Orv Hetil. 2014 Nov 30;155(48):1913-21. doi: 10.1556/OH.2014.30044.
7
The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone.颈动脉斑块负担在伴有银屑病关节炎的患者中高于单纯银屑病患者。
Ann Rheum Dis. 2013 May;72(5):715-20. doi: 10.1136/annrheumdis-2012-201497. Epub 2012 Jun 26.
8
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.全球银屑病流行病学：发病率和患病率的系统评价。
J Invest Dermatol. 2013 Feb;133(2):377-85. doi: 10.1038/jid.2012.339. Epub 2012 Sep 27.
9
Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry.一项基于美国大型队列的疾病负担、合并症和治疗使用情况的特征分析：Corrona 银屑病登记处的研究结果。
J Am Acad Dermatol. 2018 Feb;78(2):323-332. doi: 10.1016/j.jaad.2017.10.012. Epub 2017 Oct 16.
10
Estimation of global and regional incidence and prevalence of abdominal aortic aneurysms 1990 to 2010.1990年至2010年腹主动脉瘤全球及区域发病率和患病率的估计
Glob Heart. 2014 Mar;9(1):159-70. doi: 10.1016/j.gheart.2013.12.009.

引用本文的文献

1
Analysis and contrast of psoriasis disease burden trends in China and globally from 1990 to 2021.1990年至2021年中国与全球银屑病疾病负担趋势的分析与对比
Front Public Health. 2025 Mar 6;13:1541292. doi: 10.3389/fpubh.2025.1541292. eCollection 2025.
2
Examining the causal association between psoriasis and bladder cancer: A two-sample Mendelian randomization analysis.探讨银屑病与膀胱癌之间的因果关联：两样本孟德尔随机化分析。
Skin Res Technol. 2024 Apr;30(4):e13663. doi: 10.1111/srt.13663.
3
Secoemestrin C Ameliorates Psoriasis-like Skin Inflammation in Mice by Suppressing the TNF-α/NF-κB Signaling Pathway.
Secoemestrin C 通过抑制 TNF-α/NF-κB 信号通路改善小鼠银屑病样皮肤炎症。
Curr Med Sci. 2024 Feb;44(1):232-240. doi: 10.1007/s11596-024-2828-8. Epub 2024 Feb 23.
4
Non-pharmacological interventions for patients with psoriasis: a scoping review.非药物干预措施治疗银屑病患者：范围综述。
BMJ Open. 2023 Nov 24;13(11):e074752. doi: 10.1136/bmjopen-2023-074752.
5
Factors associated with quality of life in Chinese people with psoriasis: a cross-sectional study.与中国人银屑病患者生活质量相关的因素：一项横断面研究。
BMC Public Health. 2023 Sep 25;23(1):1860. doi: 10.1186/s12889-023-16758-6.
6
Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study.生物疗法治疗银屑病患者的抗炎作用：前瞻性队列 FDG PET 研究。
J Nucl Cardiol. 2023 Aug;30(4):1642-1652. doi: 10.1007/s12350-023-03204-8. Epub 2023 Feb 8.
7
Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing.司库奇尤单抗治疗中度至重度银屑病：对健康相关生活质量和心理健康的影响。
Clin Cosmet Investig Dermatol. 2023 Jan 25;16:221-229. doi: 10.2147/CCID.S296544. eCollection 2023.
8
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasis.利斯库单抗治疗可改善中重度斑块型银屑病患者的长期、持久、绝对的银屑病面积和严重程度指数和健康相关生活质量：一项事后综合分析。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):855-865. doi: 10.1111/jdv.18010. Epub 2022 Mar 17.
9
Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules.银屑病中基于模型的Meta分析：生物制剂与小分子靶向药物的定量比较
Front Pharmacol. 2021 Jul 1;12:586827. doi: 10.3389/fphar.2021.586827. eCollection 2021.
10
Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial.在系统性治疗初治的中重度斑块状银屑病患者中，比较 risankizumab 和富马酸酯类药物的直接疗效：一项随机对照试验。
Br J Dermatol. 2022 Jan;186(1):30-39. doi: 10.1111/bjd.20481. Epub 2021 Aug 17.